← The Wire
ROIVNasdaq
Roivant Sciences Ltd.
Pharmaceutical Preparations · D0 · CIK 1635088
Roivant Sciences Ltd. accelerates the development and commercialization of medicines through nimble subsidiaries
$21.61B
Market cap
$34.73
Last close
+1.9%
1D
+11.1%
5D
6.4M
Volume
Price · last 39 sessions+22.5%
May 4L $28.21 · H $34.73Jun 29
141
Total filings
May 20, 2026
Last filing
03/31
Fiscal year end
425425Aug 2, 2021425FORM 8-KJul 22, 2021425FORM 8-KJul 1, 2021425425Jun 25, 2021425FORM 8-KJun 21, 2021425425Jun 9, 2021425425Jun 9, 2021425FORM 8-KMay 17, 2021425FORM 425May 3, 2021
Insider Activity
In the 90 days to Mar 26, 2026: 8 sold $236.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Fitzgerald MeghanDirector | Sell | 70,000 | $27.45 | $1.9M |
| Mar 17, 2026 | Venker EricPresident & Immunovant CEO | Sell | 200,000 | $28.24 | $5.6M |
| Mar 16, 2026 | Epperly Melissa B,Director | Sell | 41,861 | $28.68 | $1.2M |
| Feb 23, 2026 | Torti FrankPresident and Vant Chair | Sell | 587,390 | $27.51 | $16.2M |
| Feb 20, 2026 | Torti FrankPresident and Vant Chair | Sell | 1,012,610 | $27.15 | $27.5M |
| Feb 19, 2026 | Torti FrankPresident and Vant Chair | Sell | 1,400,000 | $27.42 | $38.4M |
| Feb 13, 2026 | Manchester Keith SDirector | Sell | 225,000 | $26.50 | $6.0M |
| Feb 13, 2026 | Gold Daniel AllenDirector | Sell | 225,000 | $26.50 | $6.0M |
| Feb 13, 2026 | Qvt Financial LpOther | Sell | 225,000 | $26.50 | $6.0M |
| Feb 13, 2026 | Venker EricPresident & Immunovant CEO | Sell | 200,000 | $26.49 | $5.3M |
| Feb 13, 2026 | Qvt Financial LpOther | Sell | 150,784 | $26.49 | $4.0M |
| Feb 13, 2026 | Manchester Keith SDirector | Sell | 150,784 | $26.49 | $4.0M |
| Feb 13, 2026 | Gold Daniel AllenDirector | Sell | 150,784 | $26.49 | $4.0M |
| Feb 12, 2026 | Gold Daniel AllenDirector | Sell | 275,000 | $26.76 | $7.4M |
| Feb 12, 2026 | Manchester Keith SDirector | Sell | 275,000 | $26.76 | $7.4M |
| Feb 12, 2026 | Qvt Financial LpOther | Sell | 275,000 | $26.76 | $7.4M |
| Feb 12, 2026 | Gold Daniel AllenDirector | Sell | 150,000 | $26.72 | $4.0M |
| Feb 12, 2026 | Qvt Financial LpOther | Sell | 150,000 | $26.72 | $4.0M |
| Feb 12, 2026 | Manchester Keith SDirector | Sell | 150,000 | $26.72 | $4.0M |
| Feb 11, 2026 | Gold Daniel AllenDirector | Sell | 425,000 | $26.67 | $11.3M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Barron's2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug1mo agoInvestor's Business DailyThese Two Biotech Stocks Rocketed — And One Just Broke Out1mo ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance